Pharma stocks have surged over the past couple of weeks. Growth funds with significant exposure to pharma sector will benefit from this growth.
Scheme | Date of holding | % Holding | NAV (Rs) |
K MNC | 3 Nov,2000 | 20.9 | 9.28 |
Tata Tax Savings | 30 Sep,2000 | 20.0 | 12.22 |
Birla MNC Fund (Gr) | 29 Sep,2000 | 20.0 | 29.37 |
Dundee Tax Saver (App) | 31 Aug,2000 | 17.1 | 9.88 |
K 30 | 3 Nov,2000 | 16.4 | 15.75 |
Franklin Growth Fund | 31 Aug,2000 | 15.0 | 6.63 |
Canganga | 29 Sep,2000 | 14.8 | 10.11 |
K P Prima Plus (Gr) | 30 Sep,2000 | 14.6 | 21.16 |
Canbonus | 30 Sep,2000 | 14.3 | 9.68 |
Canpep 1993 | 29 Sep,2000 | 14.3 | 20.75 |
JM Balanced Fund (Gr) | 31 Aug,2000 | 13.0 | 16.02 |
Zurich (I) Top 200(Gr) | 29 Sep,2000 | 11.4 | 12.74 |
Canglobal | 29 Sep,2000 | 11.3 | 7.09 |
Sun F&C Balanced (Gr) | 31 Aug,2000 | 11.0 | 7.91 |
DSP ML Equity Fund | 31 Aug,2000 | 10.0 | 16.72 |
JM Equity Fund (Gr) | 31 Aug,2000 | 10.0 | 10.25 |
Cantriple | 29 Sep,2000 | 10.0 | 19.53 |
Over the last week pharma stocks have appreciated significantly as is evident from the table below.
Companies | BSE – 30 | S&P CNX Nifty |
Cipla | - | 3.50% |
Dr. Reddys | 1.10% | 1.30% |
Ranbaxy | 2.40% | 3.20% |
Glaxo | 1.40% | 0.90% |
Pharma has long been ignored by funds in favour of technology, media, telecom (TMT) stocks. Given the knowledge-based nature of the industry, India’s expertise in pharma is second to none. Funds that realise this will no doubt reap the benefits over the long term.
Sorry! There are no related views on news for this company/sector.
Ajit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More
Equitymaster requests your view! Post a comment on "Pharma stocks in the limelight". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!